Atorvastatin decreases cellular proliferation and bone matrix expression in the hypercholesterolemic mitral valve.
Makkena
Babu
B
Salti
Hani
H
Subramaniam
Malayannan
M
Thennapan
Senthil
S
Bonow
Robert H
RH
Caira
Frank
F
Bonow
Robert O
RO
Spelsberg
Thomas C
TC
Rajamannan
Nalini M
NM
D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D000069059:Atorvastatin; D001857:Bone Matrix / Q000378:metabolism*; D002114:Calcinosis / Q000209:etiology* / Q000378:metabolism / Q000517:prevention & control; D002455:Cell Division / Q000187:drug effects; D006349:Heart Valve Diseases / Q000209:etiology* / Q000378:metabolism / Q000517:prevention & control; D006538:Heptanoic Acids / Q000494:pharmacology* / Q000627:therapeutic use; D006937:Hypercholesterolemia / Q000150:complications* / Q000188:drug therapy / Q000378:metabolism; D008297:Male; D008943:Mitral Valve; D011758:Pyrroles / Q000494:pharmacology* / Q000627:therapeutic use; D011817:Rabbits
D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D011758:Pyrroles; D000069059:Atorvastatin